Jonathan Todd Garland - 18 Aug 2023 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Reporting relationship: Chief Commercial Officer
Issuer ticker: CTKB
Reported as of: 18 Aug 2023
Net transaction value: -$15,533
SEC form: 4
Accepted by SEC: 21 Aug 2023, 20:10:09 UTC
Prior SEC filing: 19 May 2023
Next SEC filing: 28 Aug 2023
Source filing: View source filing
Reporting owner signature: /s/ Valerie Barnett, Attorney-in-Fact for Todd Garland

Key filing fact

Jonathan Todd Garland filed Form 4 for Cytek Biosciences, Inc. (CTKB) on 21 Aug 2023.

Key facts

This page summarizes Jonathan Todd Garland's Form 4 filing for Cytek Biosciences, Inc. (CTKB).
6 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 21 Aug 2023, 20:10.

Change

Previous filing in this sequence was filed on 19 May 2023.
Current net transaction value: -$15,533.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CTKB transaction

Common Stock

Options Exercise

Transaction value
Shares: +1,951
Change %: +33%
Price
Shares after: 7,838
Date: 18 Aug 2023
Ownership: Direct
Footnotes: F1

CTKB transaction

Common Stock

Tax liability

Transaction value: $6,430
Shares: -760
Change %: -9.7%
Price: $8.46
Shares after: 7,078
Date: 18 Aug 2023
Ownership: Direct
Footnotes: F2

CTKB transaction

Common Stock

Options Exercise

Transaction value
Shares: +2,761
Change %: +39%
Price
Shares after: 9,839
Date: 18 Aug 2023
Ownership: Direct
Footnotes: F1

CTKB transaction

Common Stock

Tax liability

Transaction value: $9,103
Shares: -1,076
Change %: -11%
Price: $8.46
Shares after: 8,763
Date: 18 Aug 2023
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CTKB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -1,951
Change %: -8.3%
Price: $0.000000
Shares after: 21,462
Date: 18 Aug 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,951
Exercise price
Footnotes: F1, F3

CTKB transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value: $0
Shares: -2,761
Change %: -6.5%
Price: $0.000000
Shares after: 39,579
Date: 18 Aug 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,761
Exercise price
Footnotes: F1, F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.

Footnote F2

Represents the number of shares withheld by and surrendered to the Issuer on August 18, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.

Footnote F3

The shares subject to the RSU Award shall vest quarterly over four years, with 12/48th of the total shares underlying the RSU Award vesting on May 18, 2023 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18.

Footnote F4

The shares subject to the RSU Award shall vest over four years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested.